WMS Developed for Third Party Service Providers Serving the Pharmaceutical Supply Chain

Built for Third Party Service Providers with Warehouse Operations

Let’s Take a Deep Dive into How the Datex Warehouse Management System Can Help Third Party Service Providers Deal with Complex Life Sciences Business Models, Regulations and Requirements

Drug manufacturers trust third party service providers including 3PLs to effectively manage, store and ship prescription drug product inventory, using economies of scale and the latest technology with the end result that drug prices can be kept under control.

Pharmaceutical Supply Chain Challenges Increases Outsourcing to 3PLs

One of the most significant issues in driving up drug prices involves medication adherence.  When drug prices are higher, patients often cannot afford to take their prescription drugs according to doctors’ orders.  When patients do not adhere to the prescribed therapeutic plan, the prescription drugs tend to be less effective.  Approximately 30 percent of American patients do not take their prescriptions drugs according to plan because of high drug prices.  The current failure of medication adherence costs the American healthcare system up to $528 billion in terms of health consequences, illnesses and deaths.

Numerous third party logistics providers involved with specialty pharmaceutical distribution now provide additional services including:

• Wholesale distribution
• 3PL title model
• Flash title model
• Order-to-cash management
• Management of inbound logistics of raw materials and components from multiple suppliers to multiple manufacturing facilities
• Consolidation hub management

Incredibly Flexible, Configurable Third Party Services Billing Engine

• Workflow-driven billing engine
• User friendly billing wizard

Datex Footprint® WMS Helps Ensure Regulatory Compliance in Complex Pharmaceutical Industry

• Electronic signature
• Comprehensive immutable audit trail
• Configuration of user roles and permissions ensures necessary security
• Time-stamped records
• Maintains electronic files that are associated to lot, serial number or item
• Tracks DEA numbers and expiration
• Department of Health & Human Services (HHS) Prescription Drug Marketing Act (PDMA)

Datex Footprint® WMS Inventory Management for Pharmaceutical/Life Sciences

• Assigns workflow-based rules and product movement to the client or project
• System allows multiple instances and units of measure of same product (or SKU) linked to the same or different clients, for client-owned inventory
• Expiration lead time can be changed on specific instances of inventory
• Raw material receipt
• Includes logic for:
  • Fluid product tank and containers
  • Silo and fluid product

Datex Footprint® WMS Offers Optional Manufacturing Execution System Module

Looking for industry-specific WMS information?

Datex Footprint® WMS Quality Management Functionality

• Document Control
• Deviation & Incident
• Quality Audit Management

Datex Footprint® WMS Offers Optional Pharma FDA Validation Services for Pharma and Life Sciences

• Operational Qualification (OQ)
• Performance Qualification (PQ)
• User Acceptance Test (UAT)
• Reverse Tractability Matrix (RTM)
• Standard Operating Procedures (SOP)

How Datex is Ideal for Pharmaceutical Industry Needs

From contract manufacturing and packaging to drug development, pharma and life sciences cold chain, Datex has the most agile warehouse management software on the market today.  Competitive with Tier 1 warehouse management systems used by information technology experts in the pharma supply chain, the Datex WMS provides real time actionable intelligence, configurable reporting and business intelligence and sophisticated functionality to help reduce warehouse and labor operating costs.

• Full service end-to-end solutions provider
  • Software
  • Hardware
  • Integrations
  • Business intelligence
  • Project management and implementation services
  • Variety of support plans
  • Array of specialized training
    • Online, in person and/or on site
    • Datex University
  • Additional client-only services to help optimize your technology investment such as:
    • Database tuning
    • Business process analysis
    • Mobile device management

Third Party Contract Service Providers Bring Tremendous Value to Pharmaceutical Supply Chain Businesses

Pharmaceutical companies across the supply chain, primarily drug manufacturers continue to outsource to third party contractors to gain technology, capacity and external expertise that is unavailable or inaccessible internally.  Datex Footprint® WMS is integration-friendly, enabling the sharing of data from multiple systems for increased visibility.  This is ideal for contract manufacturing in the pharmaceutical industry as well as for contract packaging, CDMO, CRO, CTL and other outsourced service providers including those involved with cold chain logistics and warehousing.  This is especially important for specialty pharmaceuticals and life science clinical trials.

Drug prices have increased, partially due to the high costs of innovations including such root causes as cell therapy, new drug discovery and drug development, clinical trials, the scourge of counterfeit drugs and other factors.  As pharmaceutical manufacturers look for ways to curb drug prices, they have outsourced many core activities to third party providers.  Product safety, quality control and accessibility to an adequate supply of prescription drugs cannot suffer, however.

Using pharma supply chain software including warehouse management software designed to handle the complexities and regulatory compliance requirements of pharma and life sciences goods is essential to keeping costs under control.

Often, third party service providers in the life sciences industry find that they are hampered by challenges including:

• Need to transition to digital transformation of pharmaceutical supply chain, documentation, etc.
• Risk management issues associated in dealing with expensive, fragile goods such as biologics, gene therapies, advanced therapy requirements, etc.
• Investment in cold chain technologies required for specialty pharmaceuticals
• The need for streamlined manufacturing and distributing operational processes